Published in

Taylor and Francis Group, Leukemia & Lymphoma, 14(64), p. 2296-2305, 2023

DOI: 10.1080/10428194.2023.2254876

Links

Tools

Export citation

Search in Google Scholar

Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO